Hypertension in Cardiorenal Diseases

Dear Colleagues,

The number of patients with or at risk for coexisting kidney and heart diseases, often named “cardiorenal” or “renocardiac” syndromes, is increasing worldwide. A lot of studies documented higher mortality and significant morbidity in these kinds of patients. The interactions between kidney and heart diseases lead to a complex pathophysiology with typical disease features, and to the need for specific treatment and specialized care that may not be adequately addressed by cardiologists or nephrologists. Moreover, in addition to new drugs, recent advances in medical technologies and devices could offer the opportunity to improve treatments. Everywhere, independent of care settings, there is an urgent, unsatisfied need to take care of patients with combined kidney and heart diseases. In such a context, hypertension plays a pivotal role, since a significant fraction of these patients, in fact, exhibits higher blood pressure.

We are pleased to invite you to contribute to the empowerment of this important field of research with original research articles and reviews. Research areas may include (but are not limited to) the following: hypertension, CKD, HF, cardiorenal syndromes, diabetes mellitus in CKD and HF, and imaging in hypertension.

We look forward to receiving your contributions.

Dr. Caterina Carollo
Dr. Giuseppe Mule
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of CardioRenal Medicine is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.